HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evangelia G Kranias Selected Research

protein phosphatase inhibitor-1

12/2006Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evangelia G Kranias Research Topics

Disease

46Heart Failure
01/2020 - 01/2002
16Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019 - 02/2003
11Cardiac Arrhythmias (Arrythmia)
02/2022 - 10/2007
10Cardiomyopathies (Cardiomyopathy)
02/2022 - 01/2006
10Hypertrophy
01/2020 - 01/2002
10Reperfusion Injury
01/2018 - 04/2005
9Ischemia
01/2014 - 02/2003
7Infarction (Infarctions)
01/2019 - 04/2005
7Cardiomegaly (Heart Hypertrophy)
04/2015 - 03/2003
5Ventricular Tachycardia
02/2022 - 01/2007
5Myocardial Infarction
11/2015 - 09/2009
5Necrosis
11/2015 - 03/2007
4Fibrosis (Cirrhosis)
04/2019 - 04/2002
4Heart Diseases (Heart Disease)
01/2014 - 05/2006
3Infections
01/2012 - 11/2008
2Acidosis
01/2014 - 04/2005
2Sudden Death
10/2013 - 10/2011
2Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
11/2011 - 03/2003
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2009 - 02/2004
2Muscular Diseases (Myopathy)
11/2009 - 02/2006
2Cardiotoxicity
09/2009 - 11/2008
1Gout
01/2020
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2020
1Hyperlipidemias (Hyperlipidemia)
01/2020
1Insulin Resistance
01/2020
1Metabolic Diseases (Metabolic Disease)
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Inflammation (Inflammations)
11/2019
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
01/2019
1Cardiac Sudden Death (Sudden Cardiac Arrest)
09/2017
1Cicatrix (Scar)
03/2013

Drug/Important Bio-Agent (IBA)

36phospholambanIBA
02/2022 - 01/2002
22CalciumIBA
10/2021 - 02/2003
15Proteins (Proteins, Gene)FDA Link
10/2021 - 04/2002
9Histidine (L-Histidine)FDA Link
01/2018 - 08/2007
8Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2018 - 04/2005
8Adenosine Triphosphatases (ATPase)IBA
01/2018 - 02/2003
7Calcium-Binding ProteinsIBA
01/2018 - 10/2008
7Protein Phosphatase 1IBA
10/2017 - 04/2005
6Adrenergic Agents (Adrenergic Drugs)IBA
10/2021 - 03/2004
5Isoproterenol (Isoprenaline)FDA LinkGeneric
02/2022 - 01/2007
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2013 - 04/2002
4Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 04/2005
3Arginine (L-Arginine)FDA Link
10/2021 - 01/2006
3Calcium-Calmodulin-Dependent Protein KinasesIBA
01/2019 - 02/2010
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2019 - 02/2002
3KN 93IBA
01/2018 - 03/2007
3CatecholaminesIBA
11/2015 - 03/2003
3Small Heat-Shock ProteinsIBA
10/2011 - 04/2005
3Caspase 3 (Caspase-3)IBA
06/2010 - 04/2005
3Carrier Proteins (Binding Protein)IBA
07/2009 - 08/2007
2CholesterolIBA
01/2020 - 01/2010
2LipopolysaccharidesIBA
11/2019 - 09/2009
2Capsaicin (Zostrix)FDA Link
01/2019 - 09/2009
2Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2017
2Phosphotransferases (Kinase)IBA
01/2017 - 03/2003
2Mitochondrial Permeability Transition PoreIBA
11/2015 - 06/2010
2cysteine and glycine-rich protein 3IBA
07/2014 - 03/2004
2triadinIBA
01/2012 - 01/2008
2Creatine Kinase (Creatine Phosphokinase)IBA
03/2011 - 08/2007
2ThapsigarginIBA
06/2010 - 01/2009
2Sodium-Calcium ExchangerIBA
06/2010 - 05/2009
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2010 - 03/2007
2Pharmaceutical PreparationsIBA
01/2010 - 07/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2009 - 11/2008
2Protein Isoforms (Isoforms)IBA
07/2009 - 07/2009
2EnzymesIBA
07/2009 - 06/2002
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
06/2008 - 02/2002
2Peptides (Polypeptides)IBA
03/2007 - 02/2006
2Adenosine Triphosphate (ATP)IBA
02/2004 - 02/2003
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1Pyruvic Acid (Pyruvate)IBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
01/2020
1Probenecid (Benemid)FDA LinkGeneric
01/2020
1Inositol 1,4,5-TrisphosphateIBA
01/2020
1EndotoxinsIBA
11/2019
1Monoclonal AntibodiesIBA
04/2019
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2019
1Amino AcidsFDA Link
01/2018
1acetovanillone (apocynin)IBA
01/2018
1Cyclophilins (Cyclophilin)IBA
11/2015
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2015
1salicylhydroxamic acid (SHAM)IBA
03/2013
1Troponin IIBA
01/2013
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
03/2012
1Culture MediaIBA
01/2012
1Small Interfering RNA (siRNA)IBA
01/2012
1TropomyosinIBA
11/2011
1Transcription Factors (Transcription Factor)IBA
04/2011
1CalpainIBA
03/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2010
1Ru 360IBA
06/2010
12- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA
06/2010
1Dantrolene (Dantrium)FDA LinkGeneric
06/2010
1Ruthenium RedIBA
06/2010
1KN 92IBA
06/2010

Therapy/Procedure

5Therapeutics
01/2020 - 05/2006